Abstract: An ultrasonic transducer for measuring a part with a coating having at least one acoustic transducer, and a buffer delay line having an impedance matched to an impedance of the coating.

Abstract: A data distribution center associated with a broadband network system wherein the first broadband network system further includes at least one broadband interface unit (BIntU) transceiver comprising a receiver portion and a transmitter portion. The receiver portion is configured to receive user defined protocol with value-added (UDPVA) packet from the BIntU transceiver. The transmitter portion is configured to transmit return packets that is triggered in response to the UDPVA packets, wherein the data distribution center indicates to the BIntU transceiver that the UDPVA packets forwarded by the BIntU transceiver to the data distribution center are being received by the data distribution center or a second BIntU transceiver.

Abstract: A broadband network system configured to transfer user datagram protocol with value-added (UDPVA) packet from to a broadband interface unit (BIntU) transceiver. The broadband network system may comprise a data distribution center and the BIntU transceiver. The BIntU transceiver is configured to generate the UDPVA packet. The BIntU transceiver includes an encoder/decoder (codec) configured to alternatively code or decode UDP frame information and a digital signal processor (DSP) portion. The DSP portion is coupled to the codec. In one aspect, the DSP portion includes a stack that temporarily stores the UDPVA packet within the stack. In one aspect, the UDPVA packet is in a form to be transmitted directly to a network destination address device. In another aspect, the UDPVA packet is available to delivery to a network destination address or storage located on a local area network or a wide area network.

Abstract: A first broadband interface unit (BIntU) transceiver that is associated with a broadband network system wherein the first broadband network system further includes a data distribution center. The first BIntU transceiver comprising a transmitter portion. The transmitter portion is configured to transmit user defined protocol with value-added (UDPVA) packet to the data distribution center. The first BIntU transceiver is configured to interface with the data distribution center or a second BIntU transceiver to indicate that the UDPVA packets are transmitted from the first BIntU transceiver to the data distribution center or the second BIntU transceiver are being received respectively by the data distribution center or by the second BIntU transceiver.

Abstract: An ignition coil contains an elongated substantially circular coil core which includes a primary coil and a secondary coil each disposed radially outwardly of the core with the core composed of a plurality of generally rectangular elements at least some of which have a different width than others and the elements being in surface-to-surface contact with each other. The lateral walls of the elements may have a shape which is not perpendicular to the longitudinal extent of the elements. The core may be welded at its ends. A core contained within this ignition coil, which may be an automotive ignition coil, is disclosed.

Abstract: The present invention is directed to the use of an inhibitor of NO activity, such as a nitric oxide scavenger or an NO synthase inhibitor, as as an adjunct to treatment of inappropriate tissue vascularization disorders.

Abstract: The present invention is directed to the use of an inhibitor of NO activity, such as a nitric oxide scavenger or an NO synthase inhibitor, as an antitumor therapy to reduce tumor blood flow and oxygenation. The invention is also directed to administration of a nitric oxide scavenger or a nitric oxide synthase inhibitor to enhance the effectiveness of tumor therapy with hypoxic or acidic chemotherapeutic agents or hyperthermia. The invention is also directed to the administration of a nitric oxide synthase substrate to a subject previously administered a nitric oxide synthase inhibitor, in order to selectively inhibit tumor perfusion. In a specific example, administration of cell free hemoglobin, a nitric oxide scavenger, in conjunction with mitomycin C, a hypoxic cytotoxin, results in a significant delay in tumor growth of a human tumor xenograft in a mouse compared to mitomycin C alone.

Abstract: The present invention is directed to administration of a nitric oxide scavenger or a nitric oxide synthase inhibitor to enhance the effectiveness of tumor therapy with hypoxic or acidic chemotherapeutic agents or hyperthermia. In a specific example, administration of cell free hemoglobin, a nitric oxide scavenger, in conjunction with mitomycin C, a hypoxic cytotoxin, results in a significant delay in tumor growth of a human tumor xenograft in a mouse compared to mitomycin C alone.

Abstract: The present invention is directed to the use of an inhibitor of NO activity, such as a nitric oxide scavenger or an NO synthase inhibitor, as an antitumor therapy to reduce tumor blood flow and oxygenation. The invention is also directed to administration of a nitric oxide scavenger or a nitric oxide synthase inhibitor to enhance the effectiveness of tumor therapy with hypoxic or acidic chemotherapeutic agents or hyperthermia. The invention is also directed to the administration of a nitric oxide synthase substrate to a subject previously administered a nitric oxide synthase inhibitor, in order to selectively inhibit tumor perfusion. In a specific example, administration of cell free hemoglobin, a nitric oxide scavenger, in conjunction with mitomycin C, a hypoxic cytotoxin, results in a significant delay in tumor growth of a human tumor xenograft in a mouse compared to mitomycin C alone.

Abstract: The invention is directed to a method for the prophylaxis or treatment of an animal for deleterious physiological effects such as systemic hypotension caused by nitric oxide production induced by a biological response modifier. Examples of such biological response modifiers include but are not limited to a cytokine and an endotoxin. The invention is also directed to a method for the treatment of septic shock. Hemoproteins such as hemoglobin, myoglobin, hemalbumin and methemalbumin, for example, are useful when administered to a hypotensive patient.